Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001596783-24-000045
Filing Date
2024-07-30
Accepted
2024-07-30 16:30:45
Documents
2
Period of Report
2024-07-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1722371438.html 4  
1 FORM 4 wk-form4_1722371438.xml 4 5877
2 EX-24 arispoa.txt EX-24 1540
  Complete submission text file 0001596783-24-000045.txt   8929
Mailing Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873
Business Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 (732) 537-6200
Catalent, Inc. (Issuer) CIK: 0001596783 (see all company filings)

EIN.: 208737688 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CATALENT, INC. 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873
Business Address
Gennadios Aristippos (Reporting) CIK: 0001612357 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36587 | Film No.: 241157940